Immune checkpoint inhibitor therapy for pediatric cancers: A mini review of endocrine adverse events

Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology
Kenji Ihara

Abstract

In recent years, immune checkpoint inhibitor therapy has attracted a great deal of attention in the field of cancer treatment. In the clinical setting, antibodies targeting programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) have been successfully used to treat adult patients with various types of intractable cancer. However, in a substantial number of patients, ICI therapy is associated with autoimmune toxicities known as immune-related adverse events (IRAEs). Endocrinopathies, such as hypophysitis or autoimmune thyroid disease, may occur and can present unique clinical features that have not been documented with traditional chemotherapies. A Japanese clinical trial evaluating the anti-PD-1 antibody nivolumab for the treatment of pediatric patients with refractory malignant solid tumors and Hodgkin lymphoma has been ongoing since 2017. Moreover, tumors associated with Lynch syndrome, a hereditary form of mismatch repair deficiency, are being focused and represent the next target for ICI therapy in Japan. For the safe management of pediatric cancer patients treated with ICIs, pediatric endocrinologists must be aware of the risk of autoimmune endocrinopathies and perform relevant screening tes...Continue Reading

References

Jul 9, 2003·The Journal of Experimental Medicine·Mohammed Javeed I AnsariMohamed H Sayegh
May 14, 2004·The New England Journal of Medicine·George S Eisenbarth, Peter A Gottlieb
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Mar 28, 2007·Immunology·Ryungsa KimKazuaki Tanabe
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
May 5, 2009·European Journal of Endocrinology·George J Kahaly
Oct 24, 2009·The Journal of Clinical Endocrinology and Metabolism·Anna L MitchellSimon H S Pearce
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nitya JainJoonsoo Kang
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Nov 16, 2010·Seminars in Oncology·Anna Maria Di GiacomoMichele Maio
Nov 20, 2010·European Journal of Endocrinology·Le MinCarolyn Becker
Dec 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Virginia A PedicordJames P Allison
Jan 21, 2011·Cancer Metastasis Reviews·Trina J Stewart, Mark J Smyth
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Mar 9, 2013·The Journal of Clinical Endocrinology and Metabolism·Salvatore Maria CorselloFrancesco Torino
Mar 8, 2014·Oncoimmunology·Stéphane ChampiatJean Charles Soria
Apr 4, 2014·Science Translational Medicine·Shintaro IwamaPatrizio Caturegli
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Oct 21, 2014·Nature Medicine·Desirée SchubertBodo Grimbacher
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elena M StoffelUNKNOWN European Society of Clinical Oncology
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A PostowJedd D Wolchok
Feb 3, 2015·Nature Genetics·Adam ShlienUNKNOWN Biallelic Mismatch Repair Deficiency Consortium
Feb 19, 2015·The New England Journal of Medicine·Ignacio Melero, Juan J Lasarte
Mar 24, 2015·Trends in Immunology·Kristen E Pauken, E John Wherry
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Nov 5, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Melinda S MerchantCrystal L Mackall
Jun 17, 2016·The Oncologist·Elisa González-RodríguezUNKNOWN Spanish Group for Cancer Immuno-Biotherapy (GETICA)
Sep 9, 2016·Immunotherapy·Christina K LettieriPooja Hingorani
Jan 21, 2017·Nature Reviews. Endocrinology·David J ByunMonica Girotra
Apr 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert ChenUNKNOWN KEYNOTE-087
May 19, 2017·Journal for Immunotherapy of Cancer·James Luke GodwinColleen Veloski
Jun 15, 2017·Case Reports in Oncology·Li LiAlan B Grosbach
Jun 18, 2017·Cancer Treatment Reviews·Jeong A Park, Nai-Kong V Cheung
Jun 21, 2017·Cold Spring Harbor Perspectives in Medicine·Kroopa JoshiSergio A Quezada
Aug 19, 2017·Journal of Endocrinological Investigation·G J Kahaly, L Frommer
Jun 28, 2018·Paediatric Drugs·Mary Frances WedekindTimothy P Cripe

❮ Previous
Next ❯

Citations

Oct 1, 2019·British Journal of Haematology·Sharon M CastellinoKara M Kelly
Sep 2, 2020·Pediatric Blood & Cancer·Satyajit RayDermot Murphy
Oct 27, 2020·Current Opinion in Pediatrics·Xingyuan FangSarah E Henrickson
Mar 28, 2021·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K RzeniewiczS Turajlic
May 2, 2021·NPJ Precision Oncology·Malak AbedalthagafiMusa AlHarbi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

JNCI Cancer Spectrum
Monica GirotraInvestigational Drug Steering Committee (IDSC) Immunotherapy Task Force collaboration
Annals of the Rheumatic Diseases
Laura C CappelliClifton O Bingham
BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Daphne Day, Aaron R Hansen
© 2021 Meta ULC. All rights reserved